Protective effect of selenium-enriched lactobacillus on CCl4-induced liver injury in mice and its possible mechanisms

Table 1 Changes of AST and ALT activities in mice with hepatic injury after Se-enriched lactobacillus treatment (mean±SE)

Index	Group	Post-injection with CCl4
		1 wk	2 wk
AST (U/mg tissue)	Normal	20.43 ± 0.54a	17.68 ± 1.21a
	Model	28.05 ± 1.03c	26.81 ± 0.46c
	L-Se	23.60 ± 0.93a	17.86 ± 1.75a
	H-Se	18.90 ± 0.94a	18.90 ± 2.26a
ALT (U/mg tissue)	Normal	31.64 ± 0.23	42.93 ± 0.42a
	Model	31.15 ± 0.32	50.61 ± 1.05c
	L-Se	30.71 ± 0.39	49.47 ± 0.26c
	H-Se	28.99 ± 0.13ac	43.64 ± 1.61a

^aP<0.05 vs model group;

^cP<0.05 vs normal group.